TrialStroke2018

Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack.

Rebecca L Brookes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.